Catyalyst Pharma (CPRX) Tops Q1 EPS by 2c
Catyalyst Pharma (NASDAQ: CPRX) reported Q1 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Catyalyst Pharma (NASDAQ: CPRX) reported Q1 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.